SCHEMBL7465211

SCHEMBL7465211

N#Cc1cccc(C(=O)CC(=O)Nc2cc(-c3cc(F)ccc3F)ccc2NC(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.40
VNN1 O95497 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
HDAC3 O15379 1/20 0.36
GRM5 P41594 1/20 0.36
ACLY P53396 1/20 0.36
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
KCNA5 P22460 1/20 0.36
KCNH2 Q12809 1/20 0.36
RAB9A P51151 1/20 0.34
VCP P55072 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5869054 0.87 KCNQ4 (0.40) GSK3BVNN1CYP3A4CYP2C9CHRM2
SCHEMBL7704377 0.84 ALDH1A1 (0.45) GSK3BVNN1GRM5RAB9AKDM4E
SCHEMBL5868790 0.80 KCNQ4 (0.40) GSK3BVNN1CYP3A4CYP2C9CHRM2
SCHEMBL7065166 0.79 VCP (0.45) GSK3BHDAC3GRM5RAB9AVCP
SCHEMBL7467152 0.79 ERCC5 (0.50) GSK3BVNN1ACLYRAB9AKDM4E
SCHEMBL7459196 0.79 MAPK14 (0.48) GSK3BVNN1GRM5RAB9AKDM4E
SCHEMBL7528469 0.79 KEAP1 (0.41) CYP3A4CYP2C9GRM5RAB9AKDM4E
SCHEMBL7459390 0.78 GSK3B (0.46) GSK3BVNN1HDAC3GRM5RAB9A
SCHEMBL5868909 0.78 KCNQ4 (0.38) GSK3BHDAC3GRM5CHRM3RAB9A
SCHEMBL7463263 0.76 GPR139 (0.45) GSK3BVNN1HDAC3GRM5RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224175-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029012-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed